Volume 6 Supplement 1
15th Paediatric Rheumatology European Society (PreS) Congress
Meeting abstracts
Edited by Wietse Kuis, Patricia Woo, Angelo Ravelli, Hermann Girschick, Michaël Hofer, Johannes Roth, Rotraud K Saurenmann, Alberto Martini, Pavla Dolezova, Janjaap van der Net, Pierre Quartier, Lucy Wedderburn and Jan Scott
15th Paediatric Rheumatology European Society (PreS) Congress. Go to conference site.
London, UK14-17 September 2008
Page 1 of 7
-
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S1
-
Analysis of the classical, alternative, and MBL pathways of the complement system in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P1 -
2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S2 -
The Damage Associated Molecular Pattern (DAMP) molecule S100A12 induces pro-inflammatory responses in monocytes via innate immunity signalling pathways
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P2 -
2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S3 -
The influencing of environmental and genetics factors on bone metabolism in juvenile idiopathic arthritis children
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P3 -
2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S4 -
May antihistone antibodies replace antinuclear antibodies (ANA) as a predictor of uveitis in Juvenile idiopathic arthritis?
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P4 -
2.5 Mesenchymal Stem Cell Therapy has significant clinical effect in proteoglycan induced arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S5 -
A juvenile idiopathic arthritis biobank at the Royal Children's Hospital, Melbourne, Australia
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P5 -
3.4 Physical activity in adolescents with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S6 -
Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P6 -
3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S7 -
Are genetic variants of Caspase-1 and Cryopyrin associated with systemic JIA?
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P7 -
4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S8 -
Role of Vγ9Vδ2+ γδ T cells in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P8 -
4.5 Defective phosphorylation of the interleukin 18 receptor beta-chain causes impaired NK cell function in systemic onset Juvenile Idiopathic Arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S9 -
Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P9 -
6.4 Spondylo-epiphyseal dysplasia – a physiotherapy approach
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S10 -
CD39: a regulatory role in childhood arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P10 -
7.1 Transgenic overexpression of CREM alpha in murine T cells results in an anergic phenotype with enhanced IL17 production
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S11 -
The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P11 -
7.2 Interleukin-17 (IL-17) secreting cells in synovial fluid express the "Th17" master transcription factor RORC and their numbers correlate with CCL20 levels within the joint
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S12 -
The role of synovial fluid cytokines IL-6, IL-23 and IL-17 in the pathogenesis and persistence of synovial inflammation in JIA patients
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P12 -
7.3 Successful use of anakinra, a soluble IL-1 receptor antagonist, in pediatric rheumatic diseases associated macrophage activation syndrome/reactive hemophagocytic lymphohistiocytosis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S13 -
FOXP3 expression in peripheral blood and synovial cells of patients with juvenile idiopathic arthritis: relationship with IL-17 at cytokine and molecular level
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P13 -
7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S14 -
Association between IL2RA and juvenile idiopathic arthritis (JIA) disease severity at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study (CAPS)
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P14 -
7.5 Safety data from over 1,200 patients-years of methotrexate and/or etanercept treatment in children with polyarticular or systemic juvenile rheumatoid arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S15 -
Single-nucleotide polymorphisms in the folate pathway are associated with response to methotrexate treatment in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P15 -
7.6 Long-term treatment with glucocorticoids and low bone mass: a longitudinal study in 266 children and adolescents
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S16 -
MTHFR polymorphism and red cell folate levels are not useful as biomarkers of methotrexate efficacy and toxicity in children with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P16 -
8.3 Disease patterns in Danish Juvenile Dermatomyositis patients
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S17 -
High membrane expression of CD163 by bone marrow cells is not a specific marker of macrophage activation syndrome (MAS)
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P17 -
8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S18 -
Lymph act, TCR αβ, TCR γδ cells in peripheral blood in children with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P18 -
8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S19 -
Activated CD27+ and CD27- memory B cells accumulate in the joints of patients with juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P19 -
Abstract withdrawn
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P20 -
9.1 Innate resistance of endothelial cells to the effects of glucocorticoids
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S20 -
9.2 QT interval dispersion in North Indian children with Kawasaki disease
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S21 -
Characterization of B cells in synovial fluid and tissue from patients with JIA
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P21 -
9.3 Endothelial progenitor cells and vasculogenic responses to therapy in children with primary systemic vasculitis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S22 -
Methotrexate in childhood arthritis: effects on gene expression
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P22 -
Methotrexate does not primarily affect Foxp3+ regulatory T cells in poly-articular juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P23 -
9.4 Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, autoantibody clustering and clinical correlations
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S23 -
12.2 Mevalonate kinase deficiency: Impaired isoprenoid synthesis induces IL-1beta production via activation of Rac1
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S24 -
Outcome of repeat dosing of sJIA patients with tocilizumab in one UK centre
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P24 -
12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
Citation: Pediatric Rheumatology 2008 6(Suppl 1):S25 -
Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
Citation: Pediatric Rheumatology 2008 6(Suppl 1):P25
Official journal of
Annual Journal Metrics
-
Citation Impact
3.413 - 2-year Impact Factor (2021)
3.970 - 5-year Impact Factor (2021)
1.315 - Source Normalized Impact per Paper (SNIP)
1.051 - SCImago Journal Rank (SJR)Speed
54 days to first decision for all manuscripts (Median)
68 days to first decision for reviewed manuscripts only (Median)
Usage
901,346 Downloads (2022)
661 Altmetric mentions (2021)